In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
|Videos|June 14, 2017
What Are Some Concerns Regarding Pre-Exposure Prophylaxis Treatment?
Author(s)Contagion Editorial Staff
Kenneth Mayer, MD, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.
Advertisement
Kenneth Mayer, MD, Medical Research Director, Professor of Medicine, Fenway Health, Harvard University, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.
Interview Transcript (slightly modified for readability)
“Pre-exposure prophylaxis is the use of antiretroviral medications to protect people against HIV; it’s shown to be effective if people are adherent. So, the concerns are some people might be prescribed this and not be adherent, and they could become infected, [and] not have adequate drug levels on board but select for drug resistance. Others have concerns just about the idea of giving medication to people who are otherwise healthy, but we think of this as a very important way to prevent HIV.”
Advertisement
Related to this article
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Advertisement
Advertisement
Trending on Contagion Live
1
How The Food Safety Surveillance Infrastructure Works in the US
2
Evaluating Ebola Vaccine Against Current Bundibugyo Species
3
Ebola and the Ongoing Tale of US Failures
4
Implanted Antibiotic Reduced Systemic Regimen for Orthopedic Infection
5